This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
Skip to main content
United Kingdom | EN-GB

Add a bookmark to get started

Cortex - Life Sciences Insights

| less than a minute read

An insight into second medical use patents

With the UK Supreme Court now considering its judgment on the future approach to second medical use patents in the UK, I am very much looking forward to hearing what @Juergen Dressel, Head of Global Patent Strategy at Novartis, has to say on the patentability and enforcement of such patents from his perspective at the C5 Life Sciences Conference in Amsterdam on 27th Feburary.  For those interested, a recording of the arguments @Warner-Lambert and @Mylan as made to the UK Supreme Court in the pregabalin patent case can be found here.


patents, second medical use, pregabalin, novartis, warner lambert, mylan, generics, pharmaceuticals